BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 1969915)

  • 21. Carbamazepine decreases catecholamine turnover in the rat brain.
    Waldmeier PC; Baumann PA; Fehr B; De Herdt P; Maitre L
    J Pharmacol Exp Ther; 1984 Oct; 231(1):166-72. PubMed ID: 6491972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secretion of dopa in phaeochromocytoma.
    Louis WJ; Doyle AE; Heath WC; Robinson MJ
    Br Med J; 1972 Nov; 4(5836):325-7. PubMed ID: 4637512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of a test with 0.1 g of L-DOPA on the dynamics of urinary excretion of catecholamines and DOPA in schizophrenic patients].
    Vasil'ev VN
    Vopr Med Khim; 1980; 26(6):782-6. PubMed ID: 6779421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of neurotropic drug actions on tyrosine hydroxylase activity and dopamine metabolism in clonal cell lines.
    Bräutigam M; Kittner B; Herken H
    Arzneimittelforschung; 1985; 35(1A):277-84. PubMed ID: 2859029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuronal source of plasma dihydroxyphenylalanine.
    Goldstein DS; Udelsman R; Eisenhofer G; Stull R; Keiser HR; Kopin IJ
    J Clin Endocrinol Metab; 1987 Apr; 64(4):856-61. PubMed ID: 3102548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of alpha-methyl-paratyrosine on the urinary excretion of catecholamines in patients with pheochromocytoma].
    Rivero Sánchez M; Selgas Gutiérrez R; Lorenzo Aguiar MD; Martínez Muñoz I; Beberide García JM; Almaraz Jiménez M; Rińon Aguilar C; Sánchez Sicilia L
    Rev Clin Esp; 1981 May; 161(4):235-9. PubMed ID: 7280330
    [No Abstract]   [Full Text] [Related]  

  • 27. Pheochromocytoma: urinary catecholamine excretion and insulin secretion after -methyl-p-tyrosine treatment.
    Parra A; Porcayo F; Santos D
    Helv Paediatr Acta; 1972 Jul; 27(3):309-14. PubMed ID: 4645656
    [No Abstract]   [Full Text] [Related]  

  • 28. Regulation of catecholamine biosynthesis in a transplantable rat pheochromocytoma.
    Chalfie M; Perlman RL
    J Pharmacol Exp Ther; 1977 Mar; 200(3):588-97. PubMed ID: 15098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma.
    Imperato-McGinley J; Gautier T; Ehlers K; Zullo MA; Goldstein DS; Vaughan ED
    N Engl J Med; 1987 Mar; 316(13):793-7. PubMed ID: 2881206
    [No Abstract]   [Full Text] [Related]  

  • 30. Childhood pheochromocytoma: treatment with alpha methyl tyrosine for resistant hypertension.
    Robinson RG; DeQuattro V; Grushkin CM; Lieberman E
    J Pediatr; 1977 Jul; 91(1):143-7. PubMed ID: 17659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The brain catecholamine systems in the regulation of dominance].
    Serova LI; Naumenko EV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1990; 40(3):490-6. PubMed ID: 1975967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failure of alpha-methyltyrosine to prevent hypertensive crisis in pheochromocytoma.
    Ram CV; Meese R; Hill SC
    Arch Intern Med; 1985 Nov; 145(11):2114-5. PubMed ID: 2865938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. alpha-Methyl-p-tyrosine: a review of its pharmacology and clinical use.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1981 Feb; 21(2):81-9. PubMed ID: 7009139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism of alpha-methyltyrosine in man: relationship to its potency as an inhibitor of catecholamine biosynthesis.
    Engelman K; Jéquier E; Udenfriend S; Sjoerdsma A
    J Clin Invest; 1968 Mar; 47(3):568-76. PubMed ID: 5637144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Excretion of catecholamines and metabolites in response to increased dietary phosphate intake.
    Berndt TJ; MacDonald A; Walikonis R; Chinnow S; Dousa TP; Tyce GM; Knox FG
    J Lab Clin Med; 1993 Jul; 122(1):80-4. PubMed ID: 8320494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tyrosine hydroxylase in human adrenal and pheochromocytoma: localization, kinetics, and catecholamine inhibition.
    Waymire JC; Weiner N; Schneider FH; Goldstein M; Freedman LS
    J Clin Invest; 1972 Jul; 51(7):1798-804. PubMed ID: 4402349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catecholamine content and in vitro catecholamine synthesis in peripheral human lymphocytes.
    Musso NR; Brenci S; Setti M; Indiveri F; Lotti G
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3553-7. PubMed ID: 8855800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased tyrosine hydroxylase activity in the adrenals of spontaneously hypertensive rats.
    Moura E; Pinho Costa PM; Moura D; Guimarães S; Vieira-Coelho MA
    Life Sci; 2005 May; 76(25):2953-64. PubMed ID: 15820506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [L-DOPA test for evaluating in vivo catecholamine biosynthesis in normal persons and persons with different diseases].
    Vasil'ev VN; Matlina ESh
    Vopr Med Khim; 1977; (3):332-8. PubMed ID: 888397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal catecholamine metabolism in pheochromocytoma.
    Rubio MC; Barontini MB
    Medicina (B Aires); 1985; 45(6):631-6. PubMed ID: 2878347
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.